Abstract
Preoperative distress in breast cancer patients is highly prevalent and associated with adverse post-surgical outcomes. While both virtual reality (VR) distraction and mindfulness exercises have been increasingly utilized to manage this distress, the clinical impact of integrating active mindfulness meditation into the immersive experience remains under-investigated. Here, we present a randomized controlled trial evaluating the feasibility, acceptability and preliminary efficacy of brief, first-time immersive nature and mindfulness interventions for patients admitted to the holding area prior to the operating room for breast cancer surgery. Sixty participants were randomized to receive an 8-minute preoperative VR experience with mindfulness instruction (VR+Meditation), a standard VR nature experience without audio guidance (VR Only), or Care-as-Usual (CAU). The intervention was feasible and well tolerated with zero patient dropout and minimal indications of cybersickness or general discomfort. Outcomes included patient-reported anxiety and fear, physiological measures, and a computational semantic analysis of post-operative patient interviews. Compared with standard care, both VR interventions significantly reduced self-reported anxiety and heart rate. Although no significant differences were observed between the two active intervention groups, the VR+Meditation group demonstrated a significant and clinically meaningful reduction in surgery-specific fear relative to standard care. Analysis of brief patient interviews provided convergent evidence supporting these findings, showing that patients receiving VR+Meditation used language more strongly aligned with relief than those receiving standard care.
These findings suggest that immersive VR represents a feasible and well-tolerated first-time immersive intervention for reducing preoperative distress in patients undergoing breast cancer surgery. The addition of guided mindfulness may provide additional benefit by specifically addressing surgery-related fear, supporting the hypothesis that different digital interventions may target distinct dimensions of preoperative distress. Larger randomized studies are warranted to confirm these preliminary findings.
Author summary Waiting for breast cancer surgery is an incredibly stressful experience, and high levels of anxiety before an operation can negatively impact a patient’s recovery and mental health. Because surgical wards are fast-paced, providing individualized psychological support in the moments just before an operation is challenging. In this study, we tested whether an immersive Virtual Reality (VR) experience may help reduce preoperative distress by transporting patients to a calming digital environment immediately before surgery. We compared standard VR distraction with the same immersive experience combined with guided mindfulness meditation. Both VR interventions reduced anxiety and heart rate compared with standard care. Only the group receiving VR with guided mindfulness showed a significant reduction in surgery-related fear and, when describing their experience after surgery, used language more strongly associated with relief.
Our findings suggest that immersive interventions provided to patients for the first time on the day of surgery can provide simple, well-tolerated psychological support during one of the most stressful moments in the patient journey. They also suggest that different digital approaches may influence different aspects of preoperative distress, with guided mindfulness offering additional support for surgery-related fear.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT07785245
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of Champalimaud Foundation gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵+ Senior author
Corrected some formatting errors, the figures are in low resolution, and a few other corrections have been made during the submission process.
Data Availability
All relevant data are within the manuscript and its Supporting Information files. Patient's clinical data cannot be shared publicly because they are protected by law. Data are available from the Champalimaud Foundation clinical file system for researchers who meet the criteria for access to confidential data.





